More than 500 mothers and babies suffered harm or died after receiving inadequate maternity care at Nottingham University Hospitals (NUH) NHS Trust, a major independent review has found. The Ockenden ...

Elliot Anderson, left, and Morgan Gibbs-White have starred for Forest this season Alex Livesey/Getty Images Following a remarkable season that has seen four men occupy their head coach’s office, the ...

A Seacoast entrepreneur says the construction of a data center in Nottingham would be a win for the town. Thomas Moulton is proposing to build the facility on a stretch of Route 4. The project’s ...

In the FINE-ONE trial, finerenone met its primary endpoint by significantly reducing the urinary albumin-to-creatinine ratio by 25% compared with placebo over 6 months in adults with T1D and CKD. The ...

Begun in 2005, Dot To Dot is a multi-venue affair, like Camden Crawl or The Great Escape, but which takes over Bristol one day and Nottingham the next (and, until COVID, also Manchester).

NOTTINGHAM SIMPLY ISN’T THE PLACE FOR IT. WE DON’T WANT A DATA CENTER HERE, AND I THINK A LOT OF US ARE WORRIED ABOUT THE OUTCOME TO WATER AND NATURAL RESOURCES. WITH THE DATA CENTER. DATA CENTERS ARE ...

Jane Upton’s Scenes from a Friendship offers a powerful portrait of human connection that feels both deeply personal and universally recognisable. Spanning four decades, the play follows Billy Moss ...

May 21 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday that the U.S. Food ⁠and Drug Administration had accepted its supplemental New Drug Application for finerenone and granted priority ...

“Secondary stroke remains a serious and persistent challenge, and the FDA’s Priority Review designation underscores the urgency of advancing potential new approaches in secondary stroke prevention,” ...

The trust operates the Queen's Medical Centre and Nottingham City Hospital The findings of the biggest maternity inquiry in the history of the NHS regarding failings in Nottingham hospitals will be ...

Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease priority review voucher (PRV), striking a $180 million sale that reflects the high market demand for a speedy FDA review.